US Broker Ratings

Cidara Therapeutics, Inc. (CDTX) Stock Analysis: Exploring a 22.71% Potential Upside in the Biotech Sector

Cidara Therapeutics, Inc. (NASDAQ: CDTX) is attracting attention in the healthcare sector, particularly within biotechnology, due to its innovative approaches to tackling serious diseases like cancer and invasive fungal infections...

Procore Technologies, Inc. (PCOR) Stock Analysis: Exploring a 27.71% Potential Upside in the Construction Tech Sector

Procore Technologies, Inc. (NASDAQ: PCOR), a prominent player in the technology sector specializing in application software, has caught the attention of investors with its innovative cloud-based construction management platform. Headquartered..

Donnelley Financial Solutions (DFIN) Stock Analysis: Exploring a 30% Upside Potential

Donnelley Financial Solutions, Inc. (NYSE: DFIN), a leading player in the technology sector, specifically within the Software – Application industry, boasts a market capitalization of $1.49 billion. Headquartered in Lancaster,..

Paychex, Inc. (PAYX) Stock Analysis: Potential Upside and Strong Dividend Attract Investors

Paychex, Inc. (NASDAQ: PAYX), a leader in the human capital management sector, is gaining attention from investors with its substantial market cap of $50.03 billion and robust dividend yield of..

Uber Technologies, Inc. (UBER) Stock Analysis: Robust Revenue Growth and Strong Analyst Ratings Signal Promising Upside

Uber Technologies, Inc. (NYSE: UBER) continues to be a compelling prospect for investors, with notable revenue growth and favorable analyst ratings suggesting significant potential upside. As a leading player in..

ZoomInfo Technologies Inc. (GTM) Stock Analysis: Navigating a 15% Upside Potential

ZoomInfo Technologies Inc. (NASDAQ: GTM) has become a noteworthy player in the technology sector, particularly within the software application industry. With a market capitalization of $11.33 billion, this U.S.-based company..

Cytek Biosciences, Inc. (CTKB) Investor Outlook: Navigating a 28% Potential Upside Amidst Challenging Metrics

In the dynamic landscape of the healthcare sector, Cytek Biosciences, Inc. (NASDAQ: CTKB) stands out as a key player in the medical devices industry, specializing in innovative cell analysis solutions...

ClearPoint Neuro Inc. (CLPT) Investor Outlook: A 179% Potential Upside in Medical Devices

For investors seeking opportunities in the healthcare sector, ClearPoint Neuro Inc. (NASDAQ: CLPT) presents a compelling case with its promising potential upside. Despite its modest market capitalization of $294.79 million,..

Kingsoft Cloud Holdings Limited (KC) Investor Outlook: Analyzing the 25% Upside Potential

Kingsoft Cloud Holdings Limited (NASDAQ: KC), a significant player in China’s burgeoning cloud services sector, offers a compelling investment opportunity for those looking to capitalize on the rapid growth of..

TotalEnergies SE (TTE) Stock Analysis: Strong Dividend Yield and Growth Potential

TotalEnergies SE (NYSE: TTE) stands as a formidable player in the energy sector, with a sprawling international presence and a market capitalization of $138.12 billion. As a French-based integrated oil..

Canopy Growth Corporation (CGC) Stock Analysis: Navigating Challenges with a Vision for Growth

Canopy Growth Corporation (NYSE: CGC), a key player in the healthcare sector, specifically operating within the drug manufacturers – specialty & generic industry, has been a notable name in the..

Heron Therapeutics, Inc. (HRTX) Investor Outlook: A 265% Upside Potential in Biotech

Investors with an eye on the healthcare sector might find Heron Therapeutics, Inc. (NASDAQ: HRTX) an intriguing opportunity. With a market capitalization of $199.28 million, this biotechnology firm is making..

CytomX Therapeutics (CTMX) Investor Outlook: Potential 191.88% Upside Amid Strategic Collaborations

CytomX Therapeutics, Inc. (NASDAQ: CTMX) stands at an intriguing juncture for investors, with a market capitalization of $324.88 million and a current stock price of $1.97. Despite a modest recent..

ServiceNow, Inc. (NOW) Stock Analysis: Unpacking a 29% Potential Upside Amid Robust Growth

ServiceNow, Inc. (NYSE: NOW), a leader in cloud-based digital workflow solutions, offers investors a compelling opportunity with its projected 29.08% potential upside, according to current analyst ratings. With a market..

Sapiens International (SPNS) Stock Analysis: Navigating the Peaks with a 52-Week High

Sapiens International Corporation N.V. (SPNS) has captured investor attention by reaching its 52-week high, reflecting a strong upward trajectory in its stock price. With its current price sitting at $42.71,..

National Research Corporation (NRC) Stock Analysis: High ROE and Stable Dividend Yield in Healthcare Sector

National Research Corporation (NASDAQ: NRC) stands as a pivotal player in the healthcare sector, specializing in health information services. Headquartered in Lincoln, Nebraska, NRC provides comprehensive analytics and insights that..

AppFolio, Inc. (APPF) Stock Analysis: Exploring a 26% Potential Upside for Tech-Savvy Investors

AppFolio, Inc. (NASDAQ: APPF), a leader in cloud-based software solutions for the real estate industry, has garnered significant attention in the investment community, and for good reason. With a market..

Upbound Group, Inc. (UPBD) Investor Outlook: Exploring a 43% Potential Upside

For investors seeking opportunities in the technology sector, Upbound Group, Inc. (NYSE: UPBD) presents a intriguing prospect. With its roots in the lease-to-own market, the company has carved out a..

Arcturus Therapeutics Holdings (ARCT) Stock Analysis: Exploring a Potential 308% Upside in Biotech Investments

Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT), a key player in the biotechnology sector, is attracting significant attention from investors with its groundbreaking work in developing mRNA-based therapies. With a market..

Pacific Biosciences of California (PACB) Stock Analysis: Exploring 66% Potential Upside in the Healthcare Sector

Pacific Biosciences of California, Inc. (NASDAQ: PACB) presents a compelling opportunity for investors seeking exposure in the healthcare sector, particularly within the medical devices industry. As a company specializing in..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds